Battle Of The Weight-Loss Pills Continues With A Shock

Eli Lilly stock skidded early Friday as Novo Nordisk's oral Wegovy continued to outpace Lilly's new obesity pill, Foundayo.

Apr 24, 2026 - 18:00
 0  1
Battle Of The Weight-Loss Pills Continues With A Shock
Eli Lilly stock skidded early Friday as Novo Nordisk's oral Wegovy continued to outpace Lilly's new obesity pill, Foundayo.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow